Effect of Atorvastatin on Carotid Intima Media Thickness

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

Also called NCT04306627

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Yerevan State Medical University (from the registry)
Registry
  • NCT NCT04306627
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04306627. Randomized; no masking; primary purpose treatment. Start 2020-04-15 (anticipated); primary completion 2020-10-16 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effect of Atorvastatin on Carotid Intima Media Thickness
Condition
Essential Hypertension
Condition
Hypercholesterolemia
Intervention (Drug)
Perindopril/Amlodipine and Perindopril/Amlodipine/Atorvastatin treatment
Lead sponsor
Yerevan State Medical University (class: other)
Collaborator
Servier (class: industry)

Record details

Record id
cardio:ct-nct04306627
Content hash
9abe589537dacd42dae6e505004acff48ff5264bd705e7fc800fc4296edcffa2